Related Experiment Video
Updated: Jan 13, 2026
Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease
Published on: May 20, 2024
Identification of chemicals targeting dementia genes and pathways in the Comparative Toxicogenomics Database
Scarlet Cockell1, Sean M Harris2, Rachel K Morgan2
1Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI.
Introduction:
Dementia is a public health challenge and exposures likely contribute to risk, though many have not been evaluated. We screened chemicals for enrichment with dementia genes and related pathways.
Methods:
We obtained gene lists from the Comparative Toxicogenomics Database for 1,008 chemicals and nine dementia-related pathways (e.g., Alzheimer's disease, tauopathies). We tested pairwise chemical-dementia gene enrichment using Fisher's exact tests and proportional reporting ratios (PRR), accounting for multiple comparisons with false discovery rate (FDR<1×10-6).
Results:
Of the chemicals tested, 742 (73.6%) were enriched for at least one dementia pathway and 15 with all nine pathways, including benzo(a)pyrene, ethanol, paraquat, and particulate matter. We observed 295 chemicals enriched for Alzheimer's disease, including sodium arsenite (PRR = 57.9) and 305 enriched for tauopathies, including bisphenol A (PRR=37.7).
Discussion:
We identified chemicals enriched for dementia pathways, suggesting broad classes of chemicals contribute to dementia.
